US Bancorp
PRAX icon

US Bancorp’s Praxis Precision Medicines PRAX Stock Holding History

US Bancorp’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$422K Sell
1,260
-279
-18% -$88.3K ﹤0.01% 1694
2026
Q1 		$496K Sell
1,539
-286
-16% -$88.5K ﹤0.01% 1513
2025
Q4 		$538K Buy
1,825
+1,713
+1,529% +$319K ﹤0.01% 1493
2025
Q3 		$5.94K Sell
112
-54
-33% -$2.62K ﹤0.01% 3485
2025
Q2 		$6.98K Sell
166
-700
-81% -$26.7K ﹤0.01% 3535
2025
Q1 		$32.8K Sell
866
-102
-11% -$6.37K ﹤0.01% 2948
2024
Q4 		$74.5K Sell
968
-1,321
-58% -$95.6K ﹤0.01% 2530
2024
Q3 		$132K Buy
2,289
+605
+36% +$32.7K ﹤0.01% 2252
2024
Q2 		$69.7K Buy
+1,684
New +$79.6K ﹤0.01% 2510
2022
Q3 		– Sell
-14
Closed -$1K – 4188
2022
Q2 		$1K Sell
14
-4
-22% -$427 ﹤0.01% 3993
2022
Q1 		$3K Sell
18
-32
-64% -$6.57K ﹤0.01% 3764
2021
Q4 		$15K Buy
50
+35
+233% +$10.3K ﹤0.01% 3270
2021
Q3 		$4K Buy
15
+3
+25% +$814 ﹤0.01% 3722
2021
Q2 		$3K Buy
+12
New +$4.3K ﹤0.01% 3752

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

US Bancorp's PRAX Position: Q2 2026 in Review

US Bancorp reduced its Praxis Precision Medicines (PRAX) stake by 18% in Q2 2026, selling an estimated $88.3K and leaving 1,260 shares worth $422K. The position accounts for ﹤0.01% of the portfolio, ranked #1694.

US Bancorp first reported a position in PRAX in Q2 2021 and has held it in 14 quarters since. The position peaked at $538K in Q4 2025. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • US Bancorp held 1,260 shares of Praxis Precision Medicines worth $422K as of Q2 2026.
  • US Bancorp sold 279 Praxis Precision Medicines shares in Q2 2026, an estimated $88.3K.
  • Praxis Precision Medicines made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1694 holding.
  • US Bancorp first reported a position in Praxis Precision Medicines in Q2 2021 and has held it in 14 quarters since.
  • US Bancorp's Praxis Precision Medicines position peaked at $538K in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.